Search

Search Constraints

You searched for: Author/Creator Yang, Lingfeng

Search Results

1. Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials. Issue 1 (December 2016)

2. Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Issue 1 (14th March 2019)

9. Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies. Issue 1 (December 2016)